Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial by Neven, Patrick, Jongen, Lynn, Lintermans, Anneleen, Van Asten, Kathleen, Blomme, Chantal, Lambrechts, Diether, Poppe, An, Wildiers, Hans, Dieudonné, Anne-Sophie, Brouckaert, Olivier, Decloedt, Jan, Berteloot, Patrick, Verhoeven, Didier, Joerger, Markus, Vuylsteke, Peter, Wynendaele, Wim, Casteels, Minne, Van Huffel, Sabine, Lybaert, Willem, Van Ginderachter, Johan, Paridaens, Robert, Vergote, Ignace, Dezentjé, Vincent Olaf, Van Calster, Ben, Guchelaar, Henk-Jan

Get full text

Abstract OT2-1-05: Prospective multicenter study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adj... by Van Asten, Kathleen, Jongen, Lynn, Dieudonné, Anne-Sophie, Lintermans, Anneleen, Blomme, Chantal, Brouckaert, Olivier, Lambrechts, Diether, Wildiers, Hans, Christiaens, Marie-Rose, Timmerman, Dirk, Van Calster, Ben, Decloedt, Jan, Berteloot, Patrick, Verhoeven, Didier, Joerger, Markus, Zaman, Khalil, Dezentjé, Vincent, Neven, Patrick

Get full text

A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with tepli... by Mathieu, Chantal, Wiedeman, Alice, Cerosaletti, Karen, Long, S. Alice, Serti, Elisavet, Cooney, Laura, Vermeiren, Joan, Caluwaerts, Silvia, Van Huynegem, Karolien, Steidler, Lothar, Blomme, Sven, Rottiers, Pieter, Nepom, Gerald T., Herold, Kevan C.

Get full text

Antiviral Responses of Tissue-resident CD49a + Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease by Cooper, Grace E, Mayall, Jemma, Donovan, Chantal, Haw, Tatt J, Budden, Kurtis F, Hansbro, Nicole G, Blomme, Evy E, Maes, Tania, Kong, Chia Wei, Horvat, Jay C, Khakoo, Salim I, Wilkinson, Tom M A, Hansbro, Philip M, Staples, Karl J

Get full text